75 related articles for article (PubMed ID: 17307969)
1. Foxing smooth muscle cells: FOXO3a-CYR61 connection.
Littlewood TD; Bennett MR
Circ Res; 2007 Feb; 100(3):302-4. PubMed ID: 17307969
[No Abstract] [Full Text] [Related]
2. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
Lee HY; Chung JW; Youn SW; Kim JY; Park KW; Koo BK; Oh BH; Park YB; Chaqour B; Walsh K; Kim HS
Circ Res; 2007 Feb; 100(3):372-80. PubMed ID: 17234971
[TBL] [Abstract][Full Text] [Related]
3. Iloprost down-regulates the expression of the growth regulatory gene Cyr61 in human vascular smooth muscle cells.
Debey S; Kirchrath L; Schrör K; Meyer-Kirchrath J
Eur J Pharmacol; 2003 Aug; 474(2-3):161-4. PubMed ID: 12921857
[TBL] [Abstract][Full Text] [Related]
4. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II.
Hilfiker A; Hilfiker-Kleiner D; Fuchs M; Kaminski K; Lichtenberg A; Rothkötter HJ; Schieffer B; Drexler H
Circulation; 2002 Jul; 106(2):254-60. PubMed ID: 12105167
[TBL] [Abstract][Full Text] [Related]
5. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
Hilfiker-Kleiner D; Kaminski K; Kaminska A; Fuchs M; Klein G; Podewski E; Grote K; Kiian I; Wollert KC; Hilfiker A; Drexler H
Circulation; 2004 May; 109(18):2227-33. PubMed ID: 15117851
[TBL] [Abstract][Full Text] [Related]
6. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis.
Tucka J; Yu H; Gray K; Figg N; Maguire J; Lam B; Bennett M; Littlewood T
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2421-8. PubMed ID: 25234814
[TBL] [Abstract][Full Text] [Related]
7. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.
Han JS; Macarak E; Rosenbloom J; Chung KC; Chaqour B
Eur J Biochem; 2003 Aug; 270(16):3408-21. PubMed ID: 12899698
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats.
Li M; Chiu JF; Mossman BT; Fukagawa NK
J Biol Chem; 2006 Dec; 281(52):40429-39. PubMed ID: 17079231
[TBL] [Abstract][Full Text] [Related]
10. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model.
Matsumae H; Yoshida Y; Ono K; Togi K; Inoue K; Furukawa Y; Nakashima Y; Kojima Y; Nobuyoshi M; Kita T; Tanaka M
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1077-83. PubMed ID: 18388330
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Satonaka H; Suzuki E; Nishimatsu H; Oba S; Takeda R; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
Circ Res; 2004 Mar; 94(5):693-700. PubMed ID: 14739159
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
13. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.
Grzeszkiewicz TM; Lindner V; Chen N; Lam SC; Lau LF
Endocrinology; 2002 Apr; 143(4):1441-50. PubMed ID: 11897702
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines: investigations of the role of Fas in apoptosis due to cytokine starvation.
Behzad H; Jamil S; Denny TA; Duronio V
Cytokine; 2007 May; 38(2):74-83. PubMed ID: 17604640
[TBL] [Abstract][Full Text] [Related]
16. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
18. G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate.
Kim YM; Lim SC; Han CY; Kay HY; Cho IJ; Ki SH; Lee MY; Kwon HM; Lee CH; Kim SG
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):861-9. PubMed ID: 21212405
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
